Valuation: Takeda Pharmaceutical Company Limited

Market Cap 8,467B 52.42B 45.85B 42.29B 39.06B 74.11B 4,999B 75.36B 505B 198B 2,463B 197B 193B P/E 2027 *
43.6x
P/E 2028 * 27.9x
Enterprise Value 12,352B 76.47B 66.89B 61.7B 56.98B 108B 7,294B 110B 737B 289B 3,593B 287B 281B EV / Sales 2027 *
2.67x
EV / Sales 2028 * 2.6x
Free-Float
99.26%
Yield 2027 *
3.81%
Yield 2028 * 3.89%
1 day-0.72%
Current month+3.96%
1 month+5.70%
3 months-6.51%
6 months+5.49%
Current year+10.84%
1 week 5,300
Extreme 5300
5,527
1 month 4,897
Extreme 4897
5,527
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer - 24/06/2026
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 73 01/01/2019
Director/Board Member 63 24/06/2026
Director/Board Member 62 01/06/2022
Date Insider Type Main position Quantity % Market Cap.
07-01Free

Executive/Senior Manager

49,558 0.0031%
07-01Free

Chief Technology Officer

125,390 0.0079%
07-01Free

Executive/Senior Manager

45,140 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%0.00%+23.59%+21.57% 52.42B
-2.33%-2.09%+50.33%+162.29% 1,060B
-0.82%-2.30%+62.97%+61.11% 619B
-0.73%-4.98%+27.22%+84.46% 438B
+0.33%-1.17%+27.98%+26.90% 333B
-0.02%-2.85%+25.27%+44.88% 282B
-3.89%-11.22%+20.78%+26.07% 267B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+20.98%+61.70% 196B
-3.72%-1.10%+13.35%+71.53% 161B
Average -0.88%-2.92%+24.32%+52.12% 362.63B
Weighted average by Cap. -0.57%-2.91%+35.11%+80.41%

Financials

2027 *2028 *
Net sales 4,630B 28.67B 25.07B 23.13B 21.36B 40.53B 2,734B 41.21B 276B 109B 1,347B 108B 105B 4,701B 29.1B 25.46B 23.48B 21.69B 41.15B 2,776B 41.84B 281B 110B 1,367B 109B 107B
Net income 184B 1.14B 996M 919M 848M 1.61B 109B 1.64B 10.98B 4.31B 53.49B 4.27B 4.18B 309B 1.91B 1.67B 1.54B 1.43B 2.71B 183B 2.75B 18.46B 7.25B 89.97B 7.19B 7.03B
Net Debt 3,886B 24.06B 21.04B 19.41B 17.93B 34.01B 2,294B 34.59B 232B 91.07B 1,130B 90.32B 88.36B 3,750B 23.22B 20.31B 18.73B 17.3B 32.83B 2,215B 33.38B 224B 87.9B 1,091B 87.18B 85.28B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
10/07/26 ¥5,359.00 -0.72% 3,123,700
09/07/26 ¥5,398.00 -0.97% 2,773,800
08/07/26 ¥5,451.00 +0.06% 3,668,900
07/07/26 ¥5,448.00 -1.25% 3,488,200
06/07/26 ¥5,517.00 +2.95% 3,686,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,359.00JPY
Average target price
6,106.87JPY
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock